Skip to main content
Equibles

MORGAN STANLEY

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 895421 NEW YORK, NY
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,214
-$7,314 QoQ
Shares Held
6,341
-53.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ATNM ranks #431 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ATNM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,214 6,341
2026-03-31 $13,528 13,597
2025-12-31 $25,934 19,070
2025-09-30 $7,549 4,719
2025-06-30 $62,579 44,700
2025-03-31 $105,868 65,758
2024-12-31 $272,326 216,134
2024-09-30 $213,736 113,691
2024-06-30 $695,249 93,953
2024-03-31 $553,233 70,656
2023-12-31 $505,696 99,547
2023-09-30 $285,850 48,286
2023-06-30 $444,204 59,866
2023-03-31 $943,912 99,885
2022-12-31 $431,036 40,473
2022-09-30 $370,268 50,172
2022-06-30 $234,030 48,655
2022-03-31 $104,284 20,408
2021-12-31 $183,718 30,569
2021-09-30 $389,590 43,972
2021-06-30 $169,977 21,489
2021-03-31 $34,968 4,589
2020-12-31 $25,654 3,289
2020-09-30 $327,008 33,747
2020-06-30 $11,504 32,683
2020-03-31 $3,031 15,624